We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

C4XD C4x Discovery Holdings Plc

-0.725 (-5.58%)
04 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.725 -5.58% 12.275 195,201 16:35:28
Bid Price Offer Price High Price Low Price Open Price
11.80 12.75
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.7M -8.16M -0.0324 -4.01 32.79M
Last Trade Time Trade Type Trade Size Trade Price Currency
17:06:02 O 15,000 12.275 GBX

C4x Discovery (C4XD) Latest News

C4x Discovery (C4XD) Discussions and Chat

C4x Discovery Forums and Chat

Date Time Title Posts
15/11/202315:10C4X Discovery Holdings plc2,879

Add a New Thread

C4x Discovery (C4XD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

C4x Discovery (C4XD) Top Chat Posts

Top Posts
Posted at 04/12/2023 08:20 by C4x Discovery Daily Update
C4x Discovery Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker C4XD. The last closing price for C4x Discovery was 13p.
C4x Discovery currently has 252,227,097 shares in issue. The market capitalisation of C4x Discovery is £32,789,523.
C4x Discovery has a price to earnings ratio (PE ratio) of -4.01.
This morning C4XD shares opened at -
Posted at 27/9/2023 06:19 by copandrobber
So little stock trading! Small volumes move price down a lot. They need to do some IR.Nothing wrong with fundamentals, full of cash and good prospects. This one is a patience game!
Posted at 01/8/2023 07:44 by 1aconic
It probably needs to be viewed in context and with realistic expectations. It probably is a good deal for shareholders if it eliminates entirely (which is should) the spector of another dilutive fund raise. We're not in an ideal world currently and biotech funding isn't flavour of the month. Just calculate the dilution of future profits on ALL assets in the portfolio if they'd raised the same money at 15p (which in the current market is about what we could realistically expect). INDV-2000 may have been a case of "taking one for the team" and in context may have created more substantial shareholder value than it sacrifices if you acknowlege that other non-dilutive funding options weren't available.

It provides funds to progress other programmes (notably Alpha4Beta7) further before partnering. If the deal on Alpha4Beta7 is better as a result, it may prove a masterstroke. We can look at Morphic's share price for reference and reflect on the fact that C4X's asset looks to be vastly superior.
Posted at 13/6/2023 22:47 by alloa2003
I dont know if anyone has noticed but PatientSeek could be a game changer for C4XD, on top of the potential drug revenues further down the line. In the test they were able to tell, using a person's DNA, which Parkinsons treatment would work best for each patient. Personal medication - the Holy Grail - with potentially massive life and cost savings for the NHS, etc.

We should be discussing this as well.
Posted at 08/6/2023 12:12 by bloomberg2
ETX work closely with C4XD !!! Something cooking
Posted at 26/4/2023 08:40 by copandrobber
This is such a good buy at this price! If anyone ventures onto this board, have a look at their half year results and then enjoy buying a great company that is totally overlooked and undervalued! This will get taken out or taken private at a significantly higher price than it is today!! You heard it here first!!
Posted at 19/1/2023 14:10 by davemac3
that RNS looks like an attempt to shore up the share price. We need some milestone payments from the partnered projects or I can see another fund raise in the not too distant future.
Posted at 02/12/2022 13:41 by alloa2003
I have been in and out of this over the years and always kept a close eye on the company. You are correct, they are getting bundled in with the speculative pharma rubbish. The AZ deal has been in negotiations for ages and people are misisng the point, the $16m payment pre-clinical trials (with $2m up front) is AZ paying C4XD to do the work themselves, madness the market has missed this. This is C4XD's biggest pre-clinical trial payment to date.

As far as funding, they had cash, then the £5m placing and now the $2m payment with more to follow. I think I read they have enought cash for at least 2 years.

As soon as one drug goes to market this will become a cash cow. Many people are also missing the point with the payments. As well as stage payment due when a compound gets to market, C4XD will get royalties forever which is where the big bucks come in. So overlooked it is unreal. Just my view, DYOR
Posted at 30/11/2022 18:27 by ivor hunch
I am a firm believer in the potential of this company. Marketcap is £57 million but there is over $1 billion deals in the pipeline, and more to come. The only reason c4xd is not flying is the market's horror of any speculative share. This week c4xd announced a mega deal with AstraZeneca. A few years ago, pre-Covid, the news would have sent the shares soaring. Instead they rose 35% in the morning then continued to fall to below this summer's issue price of 25p. It's madness really, especially if the 3 deals proceed as planned - Indivior, Sanofi and AstraZeneca - all major players.
Someone tell me what I'm missing please...
Posted at 29/11/2022 08:00 by alloa2003
Been in and out of this one over the years and looking to get back in with a large chunk if other investments come through. The share price move is madness - this is still a big deal and there is at least one huge one still to come in the short term. The up front payment is substantial and lets not forget institutions approached the company about the recent fund raising at 25p. When one or more treatments hits the market, this will release huge milestone payments and - as some people seem to forget - a royalty forever.
Posted at 25/8/2020 21:20 by the stigologist
Perfectly normal for Deputy Chair of UK Vaccine Taskforce to speak to Bill Gates

Interestingly Bill Gates is one of biggest investors in Schrodinger (SDGR) Mkt Cap $5bn

Schrodinger is the nearest equivalent to C4XD

IF C4XD share price doesn't go up soon I can see a US Company snapping them up for 100p+

The Indivior deal alone at $294m makes C4XD cheap at 100p (c.£130m Mkt Cap)

Clive today told us the NRF2/IL17/a4B7 projects have similar potential
C4x Discovery share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |